Home / Healthcare / Global Allergy Diagnostics Market
Global Allergy Diagnostics Market - Market Research Report

Global Allergy Diagnostics Market

Published Date:Jun 2025
Industry: Healthcare
Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Format: PDF
Page: 200
Forecast Period: 2025-2033
Historical Range: 2020-2024
Request Sample Enquiry Before Buying Speak to Analyst

Global Allergy Diagnostics Market Segmentation, By Product & Service (Consumables, Instruments, Services), By Test Type (In Vivo Tests, {Skin Prick Test (SPT), Intradermal Test, Patch Test}, In Vitro Tests, {Allergen-specific IgE Test, Total IgE Test, Component-resolved diagnostics (CRD), Basophil Activation Test (BAT)}, By Allergen Type (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By End User (Diagnostic Laboratories, Hospital-Based Laboratories and Clinics, Academic and Research Institutions, Other End Users)- Industry Trends and Forecast to 2033

 

Global Allergy Diagnostics Market size was valued at USD 5367.6 million in 2024 and is expected to grow at a CAGR of 10.8% during the forecast period of 2025 to 2033.

 

Global Allergy Diagnostics Market Overview

The Global Allergy Diagnostics Market prevalence of allergic conditions such as asthma, allergic rhinitis, and food allergies creates substantial growth. Market expansion is driven by three main factors, which include rising environmental pollution, lifestyle changes, and greater awareness of allergy-related health issues. Healthcare professionals use multiple diagnostic methods, including skin prick tests, specific IgE blood tests, and patch tests, to determine the exact allergens causing reactions. The combination of technological progress and better diagnostic precision, along with the increasing need for individualized allergy management, encourages wider use in medical and research applications. The global market growth benefits from rising healthcare spending alongside improved access to diagnostic services.

 

Global Allergy Diagnostics Market Scope

Factors

Description

Years Considered

·         Historical Period: 2020-2023

·         Base Year: 2024

·         Forecast Period: 2025-2033

Segments

·         By Product & Service: (Consumables, Instruments, Services)

·         By Test Type: (In Vivo Tests, {Skin Prick Test (SPT), Intradermal Test, Patch Test}, In Vitro Tests, {Allergen-specific IgE Test, Total IgE Test, Component-resolved diagnostics (CRD), Basophil Activation Test (BAT)}),

·         By Allergen Type (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens)

·         By End User: (Diagnostic Laboratories, Hospital-Based Laboratories and Clinics, Academic and Research Institutions, Other End Users)

Countries Catered

North America

·         United States

·         Canada

·         Mexico

Europe

·         United Kingdom

·         Germany

·         France

·         Spain

·         Italy

·         Rest of Europe

Asia Pacific

·         China

·         India

·         Japan

·         Australia

·         South Korea

·         Rest of Asia Pacific

Latin America

·         Brazil

·         Argentina

·         Rest of Latin America

Middle East & Africa

·         Saudi Arabia

·         South Africa

·         Rest of MEA

Key Companies

·         Thermo Fisher Scientific, Inc.

·         HYCOR Biomedical

·         EUROIMMUN Medizinische Labordiagnostika AG

·         Omega Diagnostics Group PLC

·         Lincoln Diagnostics, Inc.

·         AESKU GROUP GmbH

·         DASIT Group SPA

·         R-Biopharm AG

·         bioMérieux

·         Siemens Healthcare GmbH

Market Trends

·         Increasing demand for IVD tests for allergy diagnosis

·         Growing healthcare expenditure of effective allergy diagnostic & therapeutic products

 

Global Allergy Diagnostics Market Dynamics

The market for Global Needle-free Injectors is witnessing high rate of technological change due to increasing demand for efficient and painless drug delivery devices that are easily administered by the patients. Increasing prevalence of chronic diseases such as diabetes and osteoporosis has resulted in the need for self-administrable devices and less invasive administration methods. These injectors have substantial benefits such as low incidence of needle-stick injuries, improved patient compliance and rapid absorption of drugs. Rapid jet injectors in combination with spring-based systems have enhanced the precision and control in drug delivery systems. Wide acceptance of these devices in immunization programs and their pediatric uses will drive their demand globally. Higher prices and lack of awareness in developing regions are major restraints in these regions. Despite the challenges, R&D activities, regulatory approvals and healthcare investments will drive the growth of the market in both developed and developing economies.

 

Global Allergy Diagnostics Market Segment Analysis

The Global Allergy Diagnostics Market divides into multiple categories according to product & service types, test methods, allergen classifications, and end user applications, which demonstrate the market’s diverse diagnostic needs and applications. The market segmentation by Product & Service divides into consumables, instruments, and services. Allergen extracts, assay kits, and reagents represent the primary products in this segment because of their frequent application in repeated testing procedures. Immunoassay analysers and luminometers are essential tools for performing in vitro tests because they deliver precise results and high processing capacity. Diagnostic centres and labs have expanded their service range, which now encompasses test results analysis and interpretation along with consultation services. Test Type creates market divisions between in vivo tests and in vitro tests. The Skin Prick Test (SPT), Intradermal Test, and Patch Test qualify as in vivo tests that healthcare facilities use because they provide quick results and remain cost-effective. The increasing popularity of in vitro tests stems from their dependable performance and safe nature since they eliminate direct allergen exposure while maintaining operational efficiency. The primary in vitro tests are allergen-specific IgE test along with total IgE test, component-resolved diagnostics (CRD) and Basophil Activation Test (BAT) which enables cellular-level allergic sensitivity assessment.

 

The global market divides according to allergen type into inhaled allergens which include pollen and dust mites as well as food allergens comprising nuts and dairy as well as seafood and drug allergens such as penicillin besides other allergens like latex and insect venom. Inhaled allergens represent a major portion of diagnostic cases for asthma and rhinitis while food allergies show an upward trend especially among children. Diagnostic laboratories, hospital-based laboratories and clinics, academic and research institutions along with wellness centres and other end users make up the market's served customer base. Diagnostic laboratories achieve the highest volume of tests because of their ability to process a large number of tests simultaneously and their access to sophisticated testing technologies. Integrated healthcare delivery systems provide benefits to hospital-based laboratories, whereas research institutions push forward innovation via clinical studies and allergy research.

 

Global Allergy Diagnostics Market Regional Analysis

Distinct regional growth patterns in the Global Allergy Diagnostics Market stem from diverse healthcare systems and varying levels of allergy prevalence and awareness about diagnostic processes. North America leads the diagnostic market due to its high allergic disease rates combined with robust healthcare systems and advanced diagnostic technologies. Germany, France, and the UK drive strong performance in the European allergy diagnostic market through supportive public health initiatives and reimbursement policies. The Asia-Pacific region experiences rapid growth as higher pollution levels join increased urbanization to boost allergy disorder awareness in China, India, and Japan. Healthcare infrastructure investments, together with rising personal incomes, improve access to diagnostic services. Healthcare advancements coupled with growing awareness are leading to more allergy testing requests throughout Latin America and the Middle East & and Africa. Areas lacking diagnostic facilities and affordable services encounter immediate market entry obstacles.

 

Global Allergy Diagnostics Market Key Players

·         Thermo Fisher Scientific, Inc.

·         HYCOR Biomedical

·         EUROIMMUN Medizinische Labordiagnostika AG

·         Omega Diagnostics Group PLC

·         Lincoln Diagnostics, Inc.

·         AESKU GROUP GmbH

·         DASIT Group SPA

·         R-Biopharm AG

·         bioMérieux

·         Siemens Healthcare GmbH

 

Recent Developments

In July 2024, AliveDx received IVDR CE‑mark approval for its novel microarray immunoassay designed to detect specific IgE responses to protein allergens, boosting diagnostic precision in allergy component testing

 

In July 2024, Roche acquired microfluidic diagnostics specialist LumiraDx to strengthen its point-of-care testing capabilities, enhancing access to rapid allergy diagnostics in primary care settings.

 

Research Methodology

At Foreclaro Global Research, our research methodology is firmly rooted in a comprehensive and systematic approach to market research. We leverage a blend of reliable public and proprietary data sources, including industry reports, government publications, company filings, trade journals, investor presentations, and credible online databases. Our analysts critically evaluate and triangulate information to ensure accuracy, consistency, and depth of insights. We follow a top-down and bottom-up data modelling framework to estimate market sizes and forecasts, supplemented by competitive benchmarking and trend analysis. Each research output is tailored to client needs, backed by transparent data validation practices, and continuously refined to reflect dynamic market conditions.

Table of Contents

Chapter 1.  Introduction

1.1.  Report Description

1.2.  Key Market Segments

1.3.  Regulatory Scenario

1.4.  Executive Summary

Chapter 2.  Research Methodology

2.1.  Secondary Research

2.2.  Primary Research

2.3.  Secondary Analyst Tools and Models

Chapter 3.  Market Dynamics

3.1.  Market driver analysis

3.1.1.     Rising prevalence of allergic conditions such as asthma, allergic rhinitis, atopic dermatitis, and food allergies

3.1.2.  Escalating environmental pollution (airborne particulates, allergens) and climate change effects

3.2.  Market restraint analysis

3.2.1.     High costs associated with allergy diagnostic tests and instruments

3.3.  Market Opportunity

3.3.1.     Growing demand for food allergen testing driven by processed food consumption

3.4.  Market Challenges

3.4.1.     Fragmented market with varied regional infrastructure and inconsistent reimbursement systems

Chapter 4.  Market Variables and Outlook

4.1.  SWOT Analysis

4.1.1.  Strengths

4.1.2.  Weaknesses

4.1.3.  Opportunities

4.1.4.  Threats

4.2.  PESTEL Analysis

4.2.1.  Political Landscape

4.2.2.   Economic Landscape

4.2.3.  Social Landscape

4.2.4.  Technological Landscape

4.2.5.  Environmental Landscape

4.2.6.  Legal Landscape

4.3.  Porter’s Five Forces Analysis

4.3.1.  Bargaining Power of Suppliers

4.3.2.  Bargaining Power of Buyers

4.3.3.  Threat of Substitute

4.3.4.  Threat of New Entrant

4.3.5.  Competitive Rivalry

4.4.  Value Chain Analysis

4.5.  Covid Impact Analysis

Chapter 5.  Allergy Diagnostics Market: Test Type Estimates & Trend Analysis

5.1.  Allergy Diagnostics Market value share and forecast, (2020 to 2033)

5.2.  Incremental Growth Analysis and Infographic Presentation

5.3.  In Vivo Tests

5.3.1.  Skin Prick Test (SPT)

5.3.2.  Intradermal Test

5.3.3.  Patch Test

5.4.  In Vitro Tests

5.4.1.  Allergen-specific IgE Test

5.4.2.  Total IgE Test

5.4.3.  Component-resolved diagnostics (CRD)

5.4.4.  Basophil Activation Test (BAT)

Chapter 6.  Allergy Diagnostics Market: Allergen Type Estimates & Trend Analysis

6.1.  Allergy Diagnostics Market value share and forecast, (2020 to 2033)

6.2.  Incremental Growth Analysis and Infographic Presentation

6.3.  Inhaled Allergens

6.4.  Food Allergens

6.5.  Drug Allergens

6.6.  Other Allergens

Chapter 7.  Allergy Diagnostics Market: End User Estimates & Trend Analysis

7.1.  Allergy Diagnostics Market value share and forecast, (2020 to 2033)

7.2.  Incremental Growth Analysis and Infographic Presentation

7.3.  Diagnostic Laboratories

7.4.  Hospital-Based Laboratories and Clinics

7.5.  Academic and Research Institutions

7.6.  Other End Users

Chapter 8.  Allergy Diagnostics Market: Regional Estimates & Trend Analysis

8.1.  Allergy Diagnostics Market value share and forecast, (2020 to 2033)

8.2.  Incremental Growth Analysis and Infographic Presentation

8.3.  North America

8.4.  Europe

8.5.  Asia Pacific

8.6.  Middle East & Africa

8.7.  Latin America

Chapter 9.  Allergy Diagnostics Market: Country Estimates & Trend Analysis

9.1.  Allergy Diagnostics Market value share and forecast, (2020 to 2033)

9.2.  Incremental Growth Analysis and Infographic Presentation

9.3.  United States

9.4.  Canada

9.5.  Mexico

9.6.  United Kingdom

9.7.  France

9.8.  Germany

9.9.  Italy

9.10. Spain

9.11. China

9.12. India

9.13. Japan

9.14. South Korea

9.15. Australia

9.16. Brazil

9.17. Argentina

9.18. Saudi Arabia

9.19. South Africa

Chapter 10.      Competitive Landscape

10.1. Company Market Share Analysis

10.2. Vendor Landscape

10.3. Competition Dashboard

Chapter 11.      Company Profiles

11.1. Thermo Fisher Scientific

11.1.1. Company Overview

11.1.2. Financial Details

11.1.3. Product Analysis

11.1.4. Recent Developments

11.2. HYCOR Biomedical

11.2.1. Company Overview

11.2.2. Financial Details

11.2.3. Product Analysis

11.2.4. Recent Developments

11.3. EUROIMMUN Medizinische Labordiagnostika AG

11.3.1. Company Overview

11.3.2. Financial Details

11.3.3. Product Analysis

11.3.4. Recent Developments

11.4. Omega Diagnostics Group PLC

11.4.1. Company Overview

11.4.2. Financial Details

11.4.3. Product Analysis

11.4.4. Recent Developments

11.5. Lincoln Diagnostics, Inc.

11.5.1. Company Overview

11.5.2. Financial Details

11.5.3. Product Analysis

11.5.4. Recent Developments

11.6. AESKU GROUP GmbH

11.6.1. Company Overview

11.6.2. Financial Details

11.6.3. Product Analysis

11.6.4. Recent Developments

11.7. DASIT Group SPA

11.7.1. Company Overview

11.7.2. Financial Details

11.7.3. Product Analysis

11.7.4. Recent Developments

11.8. R-Biopharm AG

11.8.1. Company Overview

11.8.2. Financial Details

11.8.3. Product Analysis

11.8.4. Recent Developments

11.9. bioMérieux

11.9.1. Company Overview

11.9.2. Financial Details

11.9.3. Product Analysis

11.9.4. Recent Developments

11.10. Siemens Healthcare GmbH

11.10.1.            Company Overview

11.10.2.            Financial Details

11.10.3.            Product Analysis

11.10.4.            Recent Developments

Segmentation

Allergy Diagnostics Market, Product & Services Outlook (Revenue - USD Million, 2020 - 2033)

Consumables

Instruments

Services

 

Allergy Diagnostics Market, Test Type Outlook (Revenue - USD Million, 2020 - 2033)

In Vivo Tests

•          Skin Prick Test (SPT)

•          Intradermal Test

•          Patch Test

In Vitro Tests

•          Allergen-specific IgE Test

•          Total IgE Test

•          Component-resolved diagnostics (CRD)

•          Basophil Activation Test (BAT)

 

Allergy Diagnostics Market, Allergen Type Outlook (Revenue - USD Million, 2020 - 2033)

Inhaled Allergens

Food Allergens

Drug Allergens

Other Allergens

 

Allergy Diagnostics Market, End User Outlook (Revenue - USD Million, 2020 - 2033)

Diagnostic Laboratories

Hospital-Based Laboratories and Clinics

Academic and Research Institutions

Other End Users

 

Allergy Diagnostics Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Methodology

Review our research methodology and quality standards for details about source selection, validation, forecasting, and review.

At Foreclaro Global Research, our research methodology is built to deliver clear, data-backed intelligence that supports confident decision-making. By combining rigorous secondary research, primary validations, and advanced forecasting models, we produce insights that are not only reliable but also strategically relevant for our clients.

 

1. Defining the Research Framework

Every study begins with a clear understanding of our client’s goals. We establish the market scope, define critical variables, and build a research framework tailored to the specific project. This upfront clarity ensures that our findings are sharply aligned with the strategic questions being addressed.

 

2. Robust Data Collection

Our analysts extract high-integrity data from a broad mix of credible sources including government databases, annual reports, regulatory filings, trade publications, scientific journals, and trusted industry portals. This secondary research is then supported with targeted primary inputs through interviews with key industry stakeholders—such as executives, subject matter experts, and channel partners—to capture real-world insights and contextual depth.

 

3. Advanced Forecasting and Modeling

To estimate market size and growth, we employ a hybrid of top-down and bottom-up modeling techniques. Our analysts apply proven forecasting models using historical data trends, economic indicators, technology adoption rates, and demand patterns. Sensitivity analysis and scenario modeling (base, optimistic, conservative) are incorporated to account for market volatility and uncertainty.

 

4. Data Triangulation and Validation

Accuracy is non-negotiable. We cross-validate every data point by triangulating it across three dimensions: source credibility, numerical consistency, and contextual alignment. This ensures our insights are not just statistically correct but strategically dependable. Discrepancies are resolved using subject expertise and multi-perspective reviews to deliver a balanced, unbiased analysis.

 

5. Quality Assurance and Final Review

Before delivery, each report undergoes a stringent quality assurance process. Our research output is reviewed for structure, clarity, consistency, and compliance with global standards. The final deliverable is tailored for decision-makers, whether it's a comprehensive industry report, data dashboard, or strategic presentation.

 

Why Our Methodology Works

What sets us apart is our adaptive data architecture and our commitment to analytical clarity. Every study is built with flexibility to accommodate dynamic markets, while our team blends quantitative rigor with domain-specific expertise. This allows us to deliver research that goes beyond information, we deliver intelligence that leads to action.

Choose License Type

Get a Sample Report

The sample report includes key data points such as market estimates, growth rates, market size, regional insights, and market segmentation

Request Sample Report
Read the Press Release for this report

Related Reports